Aldeyra Therapeutics Inc. (ALDX)
NASDAQ · Healthcare
Aldeyra Therapeutics Inc. Total Liabilities 2020–2025
Aldeyra Therapeutics Inc. annual total liabilities history from 2020 to 2025. Total liabilities is the combined debt and financial obligations a company owes to creditors.
- Aldeyra Therapeutics Inc. total liabilities as of December 31, 2025: 27.8M, a 17.24% decrease year-over-year.
- Aldeyra Therapeutics Inc. total liabilities for 2025 were 27.8M, a 17.24% decrease from 2024.
- Aldeyra Therapeutics Inc. total liabilities for 2024 were 33.6M, a 17.77% increase from 2023.
- Aldeyra Therapeutics Inc. total liabilities for 2023 were 28.5M, a 5.78% decrease from 2022.
- Aldeyra Therapeutics Inc. total liabilities for 2022 were 30.3M.
Total Liabilities
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Aldeyra Therapeutics Inc. Annual Total Liabilities (Millions of US $) | |
|---|---|
| 2025 | $28 |
| 2024 | $34 |
| 2023 | $29 |
| 2022 | $30 |
| 2021 | $27 |
| 2020 | $24 |
Aldeyra Therapeutics Inc. Total Liabilities — FAQ
Aldeyra Therapeutics Inc. (ALDX) total liabilities over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see ALDX's total liabilities history?
The chart and table above show Aldeyra Therapeutics Inc.'s total liabilities by year and by quarter, including the growth rate.